Patients who have been treated for BRCA1/2-mutant breast cancer do not appear to have adverse pregnancy outcomes. Patients who have been treated for BRCA1/2-mutant breast cancer do not appear to have adverse pregnancy outcomes.
This retrospective cohort study assesses the cumulative incidence of pregnancy after cancer and disease-free survival in BRCA carriers diagnosed with invasive b